MUSTANG BIO, INC. Variable Lease, Cost
MUSTANG BIO, INC. (MBIO) reported Variable Lease, Cost of $117.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2025-05-14
- MUSTANG BIO, INC. variable lease, cost for the quarter ending 2025-03-31 was $117.00K, a 680.00% increase year-over-year.
- MUSTANG BIO, INC. variable lease, cost for the quarter ending 2024-03-31 was $15.00K, a 93.30% decline year-over-year.
- MUSTANG BIO, INC. variable lease, cost for the quarter ending 2023-12-31 was -$77.00K, a 139.49% decline year-over-year.
- MUSTANG BIO, INC. variable lease, cost for the quarter ending 2023-09-30 was $164.00K, a 97.59% increase year-over-year.
- MUSTANG BIO, INC. variable lease, cost for fiscal 2024 was $324.00K, a 30.62% decline from fiscal 2023.
- MUSTANG BIO, INC. variable lease, cost for fiscal 2023 was $467.00K, a 4.30% decline from fiscal 2022.
- MUSTANG BIO, INC. variable lease, cost for fiscal 2022 was $488.00K, a 18.53% decline from fiscal 2021.
- MUSTANG BIO, INC. variable lease, cost for fiscal 2021 was $599.00K, a 27.45% increase from fiscal 2020.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 3 month as first filed | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|---|
| 2025-03-31 | $117.00K 10-Q · filed 2025-05-14 | ||||
| 2024-12-31 | $324.00K 10-K · filed 2025-03-28 | ||||
| 2024-03-31 | $15.00K 10-Q · filed 2025-05-14 | -$62.00K derived: sum of 2 quarters · filed 2025-05-14 | $102.00K derived: sum of 3 quarters · filed 2025-05-14 | $258.00K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | -$77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $87.00K derived: sum of 2 quarters · filed 2025-03-28 | $243.00K derived: sum of 3 quarters · filed 2025-03-28 | $467.00K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $164.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $320.00K derived: sum of 2 quarters · filed 2023-11-14 | $544.00K 10-Q · filed 2023-11-14 | $739.00K derived: sum of 4 quarters · filed 2024-05-15 | |
| 2023-06-30 | $156.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $380.00K 10-Q · filed 2023-08-14 | $575.00K derived: sum of 3 quarters · filed 2024-05-15 | $658.00K derived: sum of 4 quarters · filed 2024-05-15 | |
| 2023-03-31 | $224.00K 10-Q · filed 2024-05-15 | $419.00K derived: sum of 2 quarters · filed 2024-05-15 | $502.00K derived: sum of 3 quarters · filed 2024-05-15 | $646.00K derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $195.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $278.00K derived: sum of 2 quarters · filed 2024-03-11 | $422.00K derived: sum of 3 quarters · filed 2024-03-11 | $488.00K 10-K · filed 2024-03-11 | |
| 2022-09-30 | $83.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $227.00K derived: sum of 2 quarters · filed 2023-11-14 | $293.00K 10-Q · filed 2023-11-14 | $445.00K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $144.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $210.00K 10-Q · filed 2023-08-14 | $362.00K derived: sum of 3 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $66.00K 10-Q · filed 2023-05-12 | $218.00K derived: sum of 2 quarters · filed 2023-05-12 | |||
| 2021-12-31 | $152.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $599.00K 10-K · filed 2023-03-30 | |||
| 2021-09-30 | $447.00K 10-Q · filed 2022-11-14 | ||||
| 2021-03-31 | $147.00K 10-Q · filed 2021-05-14 | $294.00K derived: sum of 2 quarters · filed 2022-03-23 | $383.00K derived: sum of 3 quarters · filed 2022-03-23 | $383.00K derived: sum of 4 quarters · filed 2022-03-23 | |
| 2020-12-31 | $147.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $236.00K derived: sum of 2 quarters · filed 2022-03-23 | $236.00K derived: sum of 3 quarters · filed 2022-03-23 | $470.00K 10-K · filed 2022-03-23 | |
| 2020-09-30 | $89.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $89.00K derived: sum of 2 quarters · filed 2020-11-06 | $323.00K 10-Q · filed 2020-11-06 | $520.00K derived: sum of 4 quarters · filed 2021-05-14 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $234.00K 10-Q · filed 2020-08-10 | $431.00K derived: sum of 3 quarters · filed 2021-05-14 | $555.00K derived: sum of 4 quarters · filed 2021-05-14 | |
| 2020-03-31 | $234.00K 10-Q · filed 2021-05-14 | $431.00K derived: sum of 2 quarters · filed 2021-05-14 | $555.00K derived: sum of 3 quarters · filed 2021-05-14 | $681.00K derived: sum of 4 quarters · filed 2021-05-14 | |
| 2019-12-31 | $197.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $321.00K derived: sum of 2 quarters · filed 2021-03-24 | $447.00K derived: sum of 3 quarters · filed 2021-03-24 | $684.00K 10-K · filed 2021-03-24 | |
| 2019-09-30 | $124.00K 10-Q · filed 2019-11-12 | $250.00K derived: sum of 2 quarters · filed 2020-08-10 | $487.00K 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | $126.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $363.00K 10-Q · filed 2020-08-10 | |||
| 2019-03-31 | $237.00K 10-Q · filed 2020-05-11 | $236.54M 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |